Diabetes Clinical Trials Update 2016
April 27, 2016
Gauge the burden of macrovascular and microvascular disease in diabetes.
- All
- Breaking News
- Presentation
- Webinar
- Accredited
- Non-Accredited
- Conference Video
- 6-Minute Consult
- Transformative Teachers
- Primary Care Physician
- Specialist
- Allied Health Professional
-
-
LUNG 2016
April 27, 2016Discuss the state-of-the-art updates in asthma, COPD and IPF, and describe guidelines vs. real life practice. -
6 Minutes with Dr. Christopher Buller: Chronic Coronary Occlusions in Contemporary Practice
April 26, 2016This session deals with the commonly misunderstood area of Chronic Total Occlusions in the Coronary Arteries, an area of importance for any... -
Top Diabetes Learnings of 2016: A Critical Update
April 19, 2016Appreciate the role of choosing wisely in diabetes with respect to antihyperglycemic therapy. -
6 Minutes with Dr. Robert A Hegele: Familial Hypercholesterolemia (FH)
April 19, 2016What is Familial Hypercholesterolemia and what is the burden of disease? -
Anticoagulants for Atrial Fibrillation
April 15, 2016Dr John W Eikelboom reviews the general considerations in the reversal of oral anticoagulant therapy and the emerging evidence for the use... -
Diabetes: New Therapies and Critical Update
February 26, 2016Describe the pathophysiological basis of diabetes, with an emphasis on the role of multiple mechanisms that lead to progressive loss in glycemic... -
Heart Failure: Looking Back and Moving Forward
February 26, 2016Understand the global burden of heart failure, discuss the tested pharmacological treatment options for heart failure, and Discuss ARNIs––the... -
Hypertension: Looking Back and Moving forward
January 24, 2016Understand the contemporary trends of the management of hypertension in Canada, and appreciate the critical role of ACE inhibitors in cardiometabolic... -
Bile Acid Sequestrants In The Management Of Dyslipidemia
October 2, 2014Identify the need for combination therapy in dyslipidemia, describe the barriers to reaching LDL-C goals in high-risk patients.
